alpha-Glucosidase-IN-101 (Compound 13j) is an uncompetitive alpha-glucosidase inhibitor, with an IC50 of 120 nM. alpha-Glucosidase-IN-101 properly inhibits CYP1A2, CYP2C19, and CYP2C9 isoforms of cytochrome P450. alpha-Glucosidase-IN-101 can be used in the research of diabetes[1].
Molecular Weight:
616.07
Formula:
C33H26ClN9O2
Target:
Cytochrome P450,Glycosidase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
